Literature DB >> 397620

Survey of Cryptococcus neoformans in the respiratory tract of patients with bronchopulmonary disorders and in the air.

H S Randhawa, D K Paliwal.   

Abstract

Cryptococcus neoformans was cultured from 9 (1%) of 835 clinical specimens examined from the respiratory tract of patients. These isolations came from 3 (0.4%) of the760 patients; 8 isolates were from sputum and one from urine. The fungus was not demonstrable in the air at a selected site during a 2-year study although other species of Cryptococcus, namely, C. albidus, C. ater, C. flavus, C. laurentii, C. magnus, C. terreus and C. uniguttulatus were isolated. The three C. neoformans positive patients were males, with pulmonary tuberculosis as the primary disease and history of repeated exposure to pigeon excreta in two. None of these patients manifested any overt signs and symptoms specificially attributable to cryptococcosis, nor did they receive any antifungal therapy. Repeated isolations of C. neoformans from sputum, a positive urine culture and demonstration of cryptococcal antibodies in a serum specimen, followed by negative cultures and serology, suggested that patient 1 had spontaneously recovered from an episode of benign, minimal pulmonary cryptococcosis. Patients 2 and 3 probably carried the fungus as a transient resident of the respiratory tract. The results suggest that C. neoformans is of uncommon occurrence in the respiratory tract of patients with bronchopulmonary disorders and that the isolation of the fungus from this site may not necessarily imply an etiologic relationship.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 397620     DOI: 10.1080/00362177985380591

Source DB:  PubMed          Journal:  Sabouraudia        ISSN: 0036-2174


  7 in total

1.  Cryptococcosis as an opportunistic infection in immunodeficiency secondary to paracoccidioidomycosis.

Authors:  G Benard; R C Gryschek; A J Duarte; M A Shikanai-Yasuda
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

2.  Epidemiological evidence for dormant Cryptococcus neoformans infection.

Authors:  D Garcia-Hermoso; G Janbon; F Dromer
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

3.  CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence.

Authors:  Mairi C Noverr; Peter R Williamson; Ryan S Fajardo; Gary B Huffnagle
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

4.  Cryptococcus neoformans varieties as agents of cryptococcosis in Brazil.

Authors:  R Rozenbaum; A J Gonçalves; B Wanke; M J Caiuby; H Clemente; M dos S Lazera; P C Monteiro; A T Londero
Journal:  Mycopathologia       Date:  1992-09       Impact factor: 2.574

5.  First isolation of Cryptococcus magnus from a cat.

Authors:  Rui Kano; Satoshi Hosaka; Atsuhiko Hasegawa
Journal:  Mycopathologia       Date:  2004-04       Impact factor: 2.574

6.  Isolation of saprophytic Cryptococcus neoformans from Puerto Rico: distribution and variety.

Authors:  A Ruiz; D Vélez; R A Fromtling
Journal:  Mycopathologia       Date:  1989-06       Impact factor: 2.574

7.  First report of Vulvovaginitis due to Cryptococcus magnus in Iran.

Authors:  Ali Ghajari; Ensieh Lotfali; Maryam Norouzi; Zahra Arab-Mazar
Journal:  Curr Med Mycol       Date:  2018-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.